ArticlePharmacoEconomics2025

Key Considerations for Assessing Real-World Comparative Effectiveness in the Context of the Drug Price Negotiation Program: A Case Study of Pembrolizumab.

Antal T Zemplenyi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.